chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Roughly 2 hours later he suffered with stroke; Transient ischemic attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 90-year-old male patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), on 26Sep2023 at 16:15 as dose number unknown, single (Batch/Lot number: unknown) at the age of 90 years intramuscular, in arm for immunisation; for immunisation; influenza vaccine inact split 3v (FLUZONE HIGH DOSE), on 26Sep2023 at 16:15 as dose number unknown, single (Batch/Lot number: unknown), in arm for immunisation. The patient's relevant medical history included: "Congestive heart failure" (unspecified if ongoing), notes: Congestive heart failure; "Chronic kidney disease" (unspecified if ongoing), notes: Chronic kidney disease; "Type 2 Diabetes" (unspecified if ongoing). Concomitant medication(s) included: JANUVIA; METOPROLOL; GLIMEPIRIDE; ALLOPURINOL; BUMEX. The following information was reported: CEREBROVASCULAR ACCIDENT (hospitalization), outcome "unknown", described as "Roughly 2 hours later he suffered with stroke"; TRANSIENT ISCHAEMIC ATTACK (hospitalization, medically significant), outcome "unknown", described as "Transient ischemic attack". The patient was hospitalized for cerebrovascular accident, transient ischaemic attack (start date: 26Sep2023, discharge date: 27Sep2023, hospitalization duration: 2 day(s)). The events "roughly 2 hours later he suffered with stroke" and "transient ischemic attack" required emergency room visit. The patient underwent the following laboratory tests and procedures: Blood test: unknown results, notes: Reporter stated, "What exactly are you looking for? He has blood work done every week."; Body height: "Roughly 5 foot 11 inches; Computerised tomogram: unknown results, notes: Reporter stated, "Correct and while he was in the emergency in the hospital they did performed two CT Scans and ultrasound of his carotid arteries."; Ultrasound scan: unknown results, notes: Reporter stated, "Correct and while he was in the emergency in the hospital they did performed two CT Scans and ultrasound of his carotid arteries."; Weight: roughly 150 pounds. Therapeutic measures were taken as a result of cerebrovascular accident, transient ischaemic attack.  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
Pt vaccinated with Engerix B experienced nausea, vomiting, diarrhea, abdominal cramping, low grade fever, headache, malaise, general weakness, vasovagal syncope. Lead to dehydration & subsequent hospitalization.
Developed a rash on his arm from elbow to shoulder; This spontaneous case was reported by a consumer and describes the occurrence of RASH in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014F21A, 003B21A, and 027L20A) for COVID-19 vaccination.     The medical history was not provided by the reporter. Concomitant products included ALLOPURINOL, METFORMIN, METHENAMINE, WARFARIN and ATORVASTATIN for an unknown indication.   On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced RASH. At the time of the report, RASH had not resolved.           No treatment information were provided.   Reporter did not allow further contact.
103.4 degree F fever (Tylenol, ibuprofen) Headache (Tylenol, ibuprofen) Pain in arm (Tylenol, ibuprofen) Malaise (sleep)
No additional AEs reported; underwent a temperature excursion and then were administered to patients; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 22-JUL-2021, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live ) (albumin status rHA) (M-M-R II) 0.5 milliliter (lot # T012808 was confirmed to be valid, expiration date: 14-APR-2022; route of administration, anatomical location were not reported) and varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter (lot # T040418 was confirmed to be valid, expiration date: 01-DEC-2022 00:00; route of administration, anatomical location were not reported); both for prophylaxis. The administered dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live ) (albumin status rHA) (M-M-R II) underwent a temperature excursion of 50.31 degrees Fahrenheit (F) for 1 hour. The administered dose of varicella virus vaccine live (oka/merck) (VARIVAX) underwent a temperature excursion of -14.4 degrees Celsius (C) for 15 minutes. There were no previous excursions reported for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live ) (albumin status rHA) (M-M-R II). Previous excursion for varicella virus vaccine live (oka/merck) (VARIVAX) was -11.36 C for 6 hours. No additional adverse effect was reported.   This is one of several cases received from the same reporter.; Sender's Comments:  US-009507513-2108USA003248: US-009507513-2108USA003333: US-009507513-2108USA003334: US-009507513-2108USA003335: US-009507513-2108USA003332:
24 hours after injection fever began. Also Experienced chills and headache. 36 hours after injection fever peaked and then broke. 40 hours after injection symptoms subsided.
PATIENT REPORTED SHE HAD CHILLS, FEVER, AND VOMITING THE NIGHT IMMEDIATELY AFTER RECEIVING THE VACCINE AND FELT BETTER AGAIN AFTER 1 DAY. ALSO REPORTS INJECTION SITE WAS SWOLLEN AND PAINFUL.
Localized swelling, redness, deltoid and edema of Lt arm, finger, ? feel Pt felt tired. O/E ? erythematous 3cm ?
Patient with 3 COVID vaccines who admitted to hospital with positive COVID PCR.  Provider d/c note:  "83 YO male with recent COVID diagnosis presented to ED with acute weakness and confusion.  Evaluated for stroke, which was negative.  He has recovered with supportive care and will return home with family.  Declines inpatient rehab evaluation, plans to resume outpatient PT when out of covid isolation.  Paxlovid prescribed.   Problem list: Transient weakness and confusion               -MRI negative for stroke, suspect generalized weakness from covid               -Resume outpatient therapies  COVID without hypoxia               -Prescribed paxlovid, started 11/10 Increased urinary frequency, history of stricture               -unremarkable post-void residual               -Has Urology appointment 11/23 Paroxysmal atrial fibrillation               -not on chronic anticoagulation related to falls Thyroid nodules seen on CT               -Known to family, has followed with Endocrine Hypertension               -home amlodipine Chronic orthostatic hypotension               -fall precautions, avoid over-treatment of hypertension "
Pt received varicella zoster on 2-12-13 SQ in the (R) upper thigh. 2 days later, mom reports red, sore area appx 3 " x 1 3/4" red circle. Told to give 50 mg BENADRYL Q6h, ADVIL Q6h, ice area, and cortisone cream on the area. Mom drew circle around spot. Pt came to office this morning because area increased by appx 1/2" outside circle. Doctor saw pt and instructed to continue treatment.
18DEC91 grandma reports by phone redness & severe swelling of lt upper arm extending from shoulder to elbow w/in 24 hrs of vax; seen in ER 11DEC91 t104 @ that time dx rxn to immun; also noted blood in urine;
Losing her hair after her second vaccine; This is a spontaneous report from a contactable consumer. and a non-contactable consumer (friend). A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown), via an unspecified route of administration on 05May2021 as DOSE 2, SINGLE for covid-19 immunization. The patient's medical history included covid-19. The patient's concomitant medications were not reported. The patient was diagnosed with COVID-19 prior to vaccination. Since the vaccination, it was unknown that the patient been tested for COVID-19. The patient has previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported, expiry date: unknown), via an unspecified route of administration on unspecific date as DOSE 1, SINGLE for covid-19 immunization. On 06May2021, the patient was losing her hair after her second vaccine. The event was resulted in doctor or other healthcare professional office/clinic visit. Treatment received for the event was unknown. The outcome of the event was unknown.  Follow-up attempts are completed. No further information was expected.
Initial reaction: numbness in right hand after injection.  My fingers turn white and become numb at random times for several minutes. the numbness is resolved by massaging the fingers under warm water. Chronic reaction: Itching and painful rash that came on 1-2 weeks after the 2nd Covid Vaccine injection. The rash appeared on arm and spread to chest, abdomen, back, both arms and both legs. Rash became more severe over several months to years and continues to this day. I have scars all over my body from the rash as a result of scratching the intense itching. Several courses of steroid treatment reduced the rash, and I am currently taking antihistamine daily over two and a half years after the last injection to help keep it under control.
Pt received vaccines on 4/30/18. On 5/2/18, mom reported that pt began to have a welt to his right leg, estimated at 3-4 inches, with a large knot palpated at injection site as well. Mom also reports some tactile warmth at injection site.
Redness, warmth, pain left upper arm approximately 2hr after injection of PNEUMOVAX. Then had severe pain in area, chills, syncope approximately 5hr after injection. Recurrent emesis for 4-6 hr Nausea x 24 hr.
pt recv vax 530PM 15AUG96 & late that noc pt devel an itchy raised rash on arms, face, legs, stomach which lasted 3 days;no tx given;mom reports pt has had in the past several unexplained rashes but not as intense as this incident;
Patient was admitted on 02/18/2022 with ventilator dependent acute resp failure d/t stroke.  On 02/02/2022 patient noted to be Covid Positive.  Since then patient had lingering neck shoulder and arm pain.  Patient was intubated and admitted to ICU.  Admitted with acute CVA due to left MCA occlusion complicated by malignant cerebral edema and acute hypoxic respiratory failure.  Patient was transitioned to comfort care and expired on 02/27/2022.
This spontaneous report as received from a pharmacist via company representative refers to a 76 year old female patient with no history of drug reactions or allergies. The patient's medical history included multiple cases of shingles accompanied by post herpetic neuralgia. On 28-AUG-2013 the patient was vaccinated with ZOSTAVAX injection (route, dose, lot number and expiration date not provided). On 31-AUG-2013 the patient experienced swollen face, swollen feet and swollen arm. The patient saw an unspecified physician and had been administered an unspecified steroid shot which helped with the swelling but did not completely alleviated it. The pharmacist believed that the patient might be having an allergic reaction to the neomycin component of the ZOSTAVAX. The outcome of the adverse event was reported as recovering/resolving. At the time of report the patient still had some swelling. The relatedness between vaccination with ZOSTAVAX and swollen face, swollen feet and swollen arm was not reported. Additional information has been requested.
Developed left arm redness, pain, swelling, warmth induration one day after injection. Symptoms persisted one week later without improvement. Diagnosed with left arm cellulitis.
Had her first febrile seizure at 1:15 PM and another at 4:15 PM on the same date.
Arm pain and shoulder pain. Physical therapy, acupuncture, pain medication, ice packs, heating pads, asper-cream. Multiple doctor visits and no diagnosis. Numerous calls to Dept. of Health and CDC with no prognosis.
I felt really bad, very achy, had a temperature, felt like I had the flu. I had to take two days off from work could not get out of bed, nausea, could not eat. I took a home a COVID-19 test that came back negative. I made an appointment with my pulmonologist, had x-rays done. He determined that I have long COVID-19 from when I did have COVID-19. I have an appointment scheduled with my primary care physician to be tested for cancer as my sister has now tested positive and getting treated for cancer.
Patient describes fatigue starting 4/2, improving but not resolving. States she is participating in ADLS but is needing to take breaks in between, which is unusual for her.
Kaposi's sarcoma; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 72-year-old male patient received bnt162b2 (BNT162B2), administration date 04Feb2021 (Lot number: EL9261) at the age of 72 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. Patient's family medical history was not provided. The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose 1, Lot number: EK4176), administration date: 14Jan2021, for COVID-19 vaccination. The patient did not experienced events following prior vaccinations. The following information was reported: KAPOSI'S SARCOMA (medically significant) with onset 2021, outcome "unknown", described as "Kaposi's sarcoma". The event "kaposi's sarcoma" was evaluated at the physician office visit. Caller (patient) thought he might have had an adverse reaction. He saw a video that they did in a studio where someone interviewed people. He clarified it was like a news program, he didn't know which one it was but there was a study done where people got Kaposi sarcoma as side effects from the vaccine. Something must have happened to have gotten them. Caller states he didn't inform his doctor about the side effects yet (as reported). When probed to determine when Kaposi sarcoma was diagnosed, he explained the first one (lesion) was about 6 months before the present report. The second one (lesion) was removed about a week ago. He clarified later during the call they took it out more than week ago. He clarified he had a biopsy done and with the second one when he got the results, he was handed a piece of paper that said he had Kaposi sarcoma.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101772608 Same patient/drug and different dose/AEs.
received 1st dose of Covid vaccine and then 14 days later tested positive for Covid; received 1st dose of Covid vaccine and then 14 days later tested positive for Covid; This is a spontaneous report from a contactable pharmacist reported a patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The pharmacist reported the patient received 1st dose of Covid vaccine and then 14 days later tested positive for Covid. They are wondering if patient can take 2nd dose. Outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) and then 14 days later tested positive for COVID.  No complete effect of the suspect vaccine could be reasonably achieved from first dose to protect from the targeted infection.  Further information needed for a full meaningful medical assessment.
Shingles  along scalp. Sensitivity started a couple days after second vaccine shot. Rash and blistering a couple days after that. Painful throughout - as shingles tend to be.
Patient given flu shot in left arm at work. Recalls it was given high in arm and pain immediately. Pain increased in shoulder w/limited ROM. Orthopedic evaluation revealed vaccine given into bursa. The patient is experiencing left shoulder pain that radiated down the back of his arm to the elbow. He stated that he had a flu shot about 5 weeks ago which caused some soreness in his arm and since then there has been an increase in pain and reduced range of motion. The patient is having trouble getting dressed and has been avoiding sleeping on that side at night.
Fever, stiff neck, tingling and pain in arm, upset stomach, rash, headache.
2 obvious swollen lymph nodes on collarbone and one still swollen; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 04Jun2021 at 10:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer, hypothyroidism and thyroid removal. The patient had allergy to penicillin. Concomitant medications included lovastatin (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN), ammonium succinate, calcium succinate, glutamate sodium, glycine, magnesium succinate, tocopheryl acetate, zinc difumarate hydrate (AMBEREN) and vitamin d nos (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if onging. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Jun2021 at 07:00, 7 days after vaccination, the patient experienced two obvious swollen lymph nodes on collarbone and one still swollen 14 days later at time of second dose. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the event 2 obvious swollen lymph nodes on collarbone and one still swollen was recovering at the time of this report.  The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
pt recvd vax 25MAY93 & mom reports following vax fussy, feverish, loss of appetite, shaking;
3 large bumps on left arm near elbow. One the size of a golf ball. Red and warm to the touch. Painful to patient.  Referred  to urgent care
Patient came on 2/28/21 around 4:15 PM to Pharmacy, said that he has side effect because of vaccine. I said Normally it is seen after 1st 3 to 4 days, he said complained about weakness slurred speech ect. We offered to called Ambulance He went up to door to ask him and convience him to call Ambulance he said no he don't want to call ambulance
on 2/12/21 within 12 hours, severe headache, fever, myalgias, fatigue, leg pain, difficulty walking, and shortness of breath occurred. on 2/15/21 patient still experiencing all symptoms except shortness of breath. symptoms have persisted and not improved.
Rash under arm that seems to itch and won't go away; Rash under arm that seems to itch and won't go away; Injection arm aches off and on; This is a spontaneous report from a contactable consumer (Patient). A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Batch number/Lot number was not reported), via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date, the patient experienced rash under arm that seems to itch and won't go away, and injection arm aches off and on. Patient got the second shot. Had this rash under her arm that seems to itch and won't go away. Her injection arm aches off and on. Doesn't know if it was connected to the rash and itching. The clinical outcome of the event rash and itchy was not recovered and Injection arm aches off and on was unknown.  No follow-up attempts are needed. No further information is expected.
Adminstration error, patient already recieved Flu vaccine on 10/21/2022.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in a 18-month-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included PREVNAR 13 (non-GSK manufacturer) given on 11 March 2014; varicella virus vaccine (manufacturer unspecified) given on 11 March 2014. On 11 March 2014 the subject received 4th dose of KINRIX (0.5 ml, intramuscular, left thigh) which led to a maladministration (inappropriate age at vaccine administration and wrong vaccine administered). On 12 March 2014, 1 day after vaccination with KINRIX, the subject experienced swelling injection site and warmness to touch at injection site. At the time of reporting the outcome of the events was unspecified.
Achy and felt tired, so went to bed early. When patient stepped out of bed, he fainted twice within a short period of time. He was found on the floor by wife at one point and had passed out. He then fell down and passed out on the way back to bed. Patient took some Tylenol before bed. When patient awoke the next morning, no other issues occurred.
fever(99), and chills,, stomach upset and diarrhea--also reporting a new cough that developed after the vaccine  HX of Multiple Sclerosis
Shingles.  No compromised immune system, no illness or disease, under 50, no physical injury, no long term steroid use
ABOUT SIX HOURS AFTER RECEIVING VACCINE, FELT UPPER LIP DROOPING AND FELT LIKE SHE WAS "SPACING OUT."  SYMPTOMS LASTED ABOUT 48 HOURS THEN RESOLVED SPONTANEOUSLY.  DID NOT SEEK MEDICAL ATTENTION.
p/vax pt devel a fever of 104.5 which resolved p/24 to 48hr;4/12/99 pt had several episodes of diarrhea some of which contained blood;
Tinnitus, From 1st day after Vaccination to current. Predominately in left ear but affecting both ears. Loss of hearing in left ear 40% loss.
Information has been received from a 61 year old female consumer with cholesterol, blood pressure and penicillin allergy concerning herself who on 18-JUL-2008 was vaccinated with the first dose of ZOSTAVAX (Oka/Merck) into the arm. Concomitant therapy included an unspecified natural medicine for cholesterol and blood pressure. On 20-JUL-2008 the patient developed redness about the size of two quarters and also a bruise at the injection site. The site of injection was a little warm to the touch. At the time of this report, the patient's symptoms persisted. The patient did not seek medical attention. No further information is available.
pt recv vax 1996 & 25JUL97 pt exp flu-like sx & was hosp & was dead by 28JUL97;it was reported that the COD was originally thought to be Reye's synd but it was discovered child had cardiomyopathy (swelling);lab revealed +echovirus